The monotherapy was clinically significant.
As you point out, it just missed out on statistical significance.
n=31.
A larger n in the next trial should fix that.
I'm GUESSING the next trial will be monotherapy.
- Forums
- ASX - By Stock
- Ann: ACW updated depression trial results and implications
The monotherapy was clinically significant. As you point out, it...
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACW (ASX) to my watchlist
|
|||||
Last
4.1¢ |
Change
-0.004(8.89%) |
Mkt cap ! $108.4M |
Open | High | Low | Value | Volume |
4.5¢ | 5.2¢ | 4.0¢ | $1.948M | 42.20M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 1740530 | 4.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.2¢ | 370000 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 781 | 0.041 |
9 | 1990530 | 0.040 |
6 | 1789482 | 0.039 |
8 | 1107653 | 0.038 |
4 | 639000 | 0.037 |
Price($) | Vol. | No. |
---|---|---|
0.042 | 250000 | 2 |
0.043 | 519001 | 5 |
0.044 | 809810 | 4 |
0.045 | 609252 | 6 |
0.046 | 1146175 | 7 |
Last trade - 15.46pm 27/08/2024 (20 minute delay) ? |
Featured News
ACW (ASX) Chart |
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online